Skip to content

Zlatan Stepanovic, M.D.

NPI 1710987003ActiveIndividual· Internal Medicine, Cardiovascular Disease· Hobart, IN

Internal Medicine, Cardiovascular Disease (M.D.) in Hobart, Indiana, trained at Indiana University School of Medicine (class of 1991). Their prescriptions cost Medicare Part D more than their services did: $2,253,701 for 9,803 claims, against $443,692 paid for services in 2024. Alnylam Pharmaceuticals Inc. was the largest of 20 companies reporting payments in 2025, $1,539 in all, mostly food and beverage.

Overview

NPI1710987003
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 28, 2005
Last updated in NPPESSep 24, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000X0104086AIN

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (IN)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients1,287
Services billed5,187 across 66 procedure codes
Paid by Medicare$443,692

Part D prescriptions in 2024

Prescriptions (claims)9,803 · 25,733 30-day fills
Patients1,165
Total drug cost$2,253,701
Generic share86% of claims

Medicare sources and data years

Education and affiliations

Medical schoolIndiana University School of Medicine
Graduation year1991
Medicare specialtyCardiovascular Disease (Cardiology)
Secondary specialtiesPeripheral Vascular Disease

Medical group

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$1,539 · 76 payments from 20 companies
  • 2024$1,056 · 56 payments from 18 companies

Top paying companies in 2025

CompanyAmountPayments
Alnylam Pharmaceuticals Inc.$210.8110
Astrazeneca Pharmaceuticals LP$167.9218
Pfizer Inc.$152.7310
Abiomed$149.501
Amgen Inc.$141.778

What the 2025 payments were for

  • Food and Beverage$1,539 · 76 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other cardiologists in Hobart

All cardiologists in Indiana